IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — NERV

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents24.6532.6612.2915.2517.2926.5330.8834.8246.9051.8035.9840.2249.7554.9565.5974.2180.14
Short-term Investments50.6245.41------------------------------
Total Current Assets79.7379.1113.0215.5517.9227.9431.4135.6248.2352.2336.6744.8450.0455.7067.4475.2381.69
Property, Plant & Equipment----0.000.000.000.010.010.010.010.010.01------------
Goodwill14.8714.8714.8714.8714.8714.8714.8714.8714.8714.8714.8714.8714.8714.8714.8714.8714.87
Intangible Assets----------------------------15.2015.2015.20
Total Non-current Assets*15.3614.9215.0714.8714.8714.8814.8814.8914.9114.9114.9214.9214.9214.9230.1230.1030.14
Total Assets95.0994.0328.0930.4232.8042.8146.2950.5163.1367.1451.5959.7664.9670.6297.56105.32111.83
Accounts Payable1.452.120.940.900.640.550.831.441.400.300.960.531.521.591.201.591.13
Total Current Liabilities3.964.482.672.531.954.484.202.833.351.912.502.203.413.253.084.443.36
Total Non-current Liabilities*292.69338.6060.0060.0060.0060.0086.5884.2779.8377.7475.7171.8169.9368.1166.4064.7163.10
Total Liabilities296.65343.0862.6762.5361.9564.4890.7887.1083.1879.6578.2174.0073.3471.3569.4869.1666.46
Retained Earnings(796.74)(814.20)(405.13)(402.39)(399.13)(391.10)(413.62)(405.38)(387.79)(379.97)(373.78)(360.08)(353.18)(344.47)(313.39)(304.19)(293.60)
Total Stockholder Equity(213.30)(254.01)(34.58)(32.11)(29.15)(21.67)(44.49)(36.59)(20.05)(12.51)(26.62)(14.25)(8.38)(0.74)28.0836.1745.37

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue------------------------------------0.000.00
Research & Development7.195.252.170.931.301.361.981.893.864.174.723.441.892.653.192.374.134.9618.754.51
Selling, General & Admin3.4511.422.811.922.082.542.542.482.422.512.452.642.632.691.882.842.833.032.633.00
Total Operating Expenses10.6416.674.982.843.373.904.524.376.286.687.176.084.525.355.075.216.977.9921.387.52
Operating Income(10.64)(16.67)(4.98)(2.84)(3.37)(3.90)(4.52)(4.37)(6.28)(6.68)(7.17)(6.08)(4.52)(5.35)(5.07)(5.21)(6.97)(7.99)(21.38)(7.52)
Net Income17.47(125.40)(283.67)(2.74)(3.26)(3.75)(4.27)22.51(8.23)(8.57)(9.02)(7.82)(6.19)(6.97)(6.73)(6.90)(8.72)(9.76)(21.31)(9.21)
Basic EPS0.36(2.86)(33.38)(0.36)(0.43)(0.50)(0.56)2.97(1.09)(1.13)(1.15)(1.03)(1.12)(1.31)(1.26)(1.29)----(0.50)(0.22)
Diluted EPS(0.14)(2.86)(33.38)(0.36)(0.43)(0.50)(0.56)2.97(1.09)(1.13)(1.15)(1.03)(1.12)(1.31)(1.26)(1.29)----(0.50)(0.22)

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(13.34)(5.43)(4.48)(2.92)(2.04)(4.07)(5.17)(4.35)(3.94)(6.09)(5.99)(4.81)(3.87)(0.12)(4.11)(9.53)(5.19)(5.81)(4.83)(8.63)
Investing Cash Flow(4.83)(45.29)0.000.000.000.000.000.000.000.00--0.000.000.00------------
Financing Cash Flow10.171.0874.50(0.05)0.000.00------0.000.00(0.09)19.690.000.000.00-0.00--0.000.00